Cholesterol lowering in patients with CHD and metabolic syndrome

Lancet

Volumn 369, Issue 9555, 2007, Pages 25-26

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b  

^a Sanitary Service   (Italy)

^b Ospedale di San Vito al Tagliamento   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MEGADOSE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LETTER; LIFESTYLE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; AGED; CORONARY ARTERY DISEASE; FEMALE; NOTE;

AGED; CORONARY DISEASE; DIET, MEDITERRANEAN; FEMALE; HEPTANOIC ACIDS; HUMANS; LIFE STYLE; METABOLIC SYNDROME X; PYRROLES;

EID: 33845977418     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60022-1     Document Type: Letter

References (5)

1. Deedwania P., Barter P., Carmena R., et al., for the Treating to New targets Investigators. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet 368 (2006) 919-928
2. Rimm E., and Stampfer M. Diet, lifestyle, and longevity-the next steps?. JAMA 292 (2004) 1490-1492
3. Ornish D., Scherwitz L., Billings J., et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280 (1998) 2001-2007
4. Watts G., Lewis B., Brunt J., et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339 (1992) 563-569
5. de Lorgeril M., Renaud S., Mamelle N., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343 (1994) 1454-1459